While overexpression of BCRP3 in HCT116 human colorectal cancer cell line did not affect cell viability at the basal state, it significantly increased cell viability upon treatment with a chemotherapeutic drug 5-FU (Additional file 1: Fig. S2A). This evidence concerns the gene BCRP3 and colorectal cancer.